Argon News and Research

RSS

Rex Medical receives FDA Clearance for Cleaner Rotational Thrombectomy System

Rex Medical, L.P., today announced that it has received 510(k) Clearance from the U.S. Food and Drug Administration for the Cleaner™ Rotational Thrombectomy System. Cleaner™ technology is indicated for mechanical declotting of occluded native vessel dialysis fistulae and synthetic dialysis access grafts.

11 Mar 2010

Argon Medical Devices, Rex Medical announce licensing agreement for Cleaner Rotational Thrombectomy System

Argon Medical Devices, Inc. announced today that it has entered into a definitive licensing agreement with privately held Rex Medical, LP for exclusive rights to market and distribute the Cleaner™ Rotational Thrombectomy System in the United States, European Union and Canada. Cleaner is a medical device designed for the mechanical declotting of occluded native vessel dialysis fistulae and synthetic dialysis access grafts.

10 Mar 2010

Prothesis made of nanocompound material may last more than 150 years

Current body protheses do not last more than 10-15 years. After this time, the operation has to be repeated in order to change prothesis. It is usually problematic as, in general, it is elderly people that use the procedure. Researcher Nere Garmendia, based in the Basque city of Donostia-San Sebasti-n, has just published her PhD, a thesis which may well mean the first step to solving this problem. According to Ms Garmendia, using a ceramic material called zirconia (Zr02), carbon nanotubes and nanoparticles of zirconia, a prothesis that will last more than 150 years can be produced.

24 Feb 2010

Low-temperature plasma prototype devices as bactericidal cocktails

MRSA (methicillin-resistant Staphylococcus Aureus) and other drug-resistant bacteria could face annihilation as low-temperature plasma prototype devices have been developed to offer safe, quick, easy and unfailing bactericidal cocktails.

26 Nov 2009

ATS CryoMaze Probe receives CE Mark

ATS Medical, Inc., manufacturer and marketer of state-of-the-art cardiac surgery products and services, today announced the receipt of CE Mark for the ATS CryoMaze® 10-S Surgical Cryoablation Probe for the treatment of cardiac arrhythmias.

14 Oct 2009

Varian offers new hardware and accessory options for 710-ES Series ICP-OES instruments

Varian, Inc. announced today a series of productivity enhancements for its 710-ES Series of ICP-OES (Inductively Coupled Plasma - Optical Emission Spectrometer) instruments.

13 Oct 2009

Freezing kidney cancer - interventional cryoablation

Freezing kidney tumors - using a safe minimally invasive interventional radiology treatment that kills the cancer 100 percent effectively without surgery - should be the gold standard or first treatment option for all individuals with tumors that are 4 centimeters in size or smaller.

10 Mar 2009

Cryoablation for kidney tumor patients shows promise

Mayo Clinic researchers report that freezing kidney tumors through percutaneous cryoablation shows promise for patients who are not good candidates for surgery.

30 Mar 2007

Photochemistry creates drug-trapping nanoparticles

Many of the most potent anticancer agents are poorly soluble in water, presenting a challenge for medicinal chemists who must develop methods of delivering these drugs in the watery environment of the human body.

9 Oct 2006

Cryotherapy and MRI shows tumors freezing in real time

Cryotherapy combined with magnetic resonance imaging (MRI) is giving doctors unprecedented control during liver cancer treatment by allowing them to observe the tumors freezing in real time, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA).

30 Nov 2004